Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.
2.
3.

Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults.

Treanor J, Dumyati G, O'Brien D, Riley MA, Riley G, Erb S, Betts R.

J Infect Dis. 1994 Feb;169(2):402-7.

PMID:
8106775
4.

Evaluation in children of cold-adapted influenza B live attenuated intranasal vaccine prepared by reassortment between wild-type B/Ann Arbor/1/86 and cold-adapted B/Leningrad/14/55 viruses.

Obrosova-Serova NP, Slepushkin AN, Kendal AP, Harmon MW, Burtseva EI, Bebesheva NI, Beljaev AL, Lonskaja NI, Medvedeva TE, Egorov AY, et al.

Vaccine. 1990 Feb;8(1):57-60.

PMID:
2180233
5.

Safety and immunogenicity of live attenuated cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in infants and children.

Edwards KM, King JC, Steinhoff MC, Thompson J, Clements ML, Wright PF, Murphy BR.

J Infect Dis. 1991 Apr;163(4):740-5.

PMID:
2010627
6.

Development and characterization of a live attenuated influenza B virus vaccine candidate.

Seo SU, Byun YH, Lee EY, Jung EJ, Jang YH, Kim HA, Ha SH, Lee KH, Seong BL.

Vaccine. 2008 Feb 13;26(7):874-81. doi: 10.1016/j.vaccine.2007.12.022. Epub 2008 Jan 7.

PMID:
18207290
7.
8.

Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults.

Keitel WA, Couch RB, Quarles JM, Cate TR, Baxter B, Maassab HF.

J Infect Dis. 1993 Feb;167(2):305-11.

PMID:
8421165
9.

Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren.

Khan AS, Polezhaev F, Vasiljeva R, Drinevsky V, Buffington J, Gary H, Sominina A, Keitel W, Regnery H, Lonskaya NL, Doroshenko E, Gavrilov A, Ivakhov I, Arden N, Schonberger LB, Couch R, Kendal A, Cox N.

J Infect Dis. 1996 Feb;173(2):453-6.

PMID:
8568310
10.
11.
12.

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, King J, Kotloff K, Bernstein DI, Hayden FG, Zangwill K, Yan L, Wolff M.

J Pediatr. 2000 Feb;136(2):168-75.

PMID:
10657821
13.

Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults.

Sears SD, Clements ML, Betts RF, Maassab HF, Murphy BR, Snyder MH.

J Infect Dis. 1988 Dec;158(6):1209-19.

PMID:
3198936
14.

The development of live attenuated cold-adapted influenza virus vaccine for humans.

Maassab HF, Bryant ML.

Rev Med Virol. 1999 Oct-Dec;9(4):237-44. Review.

16.
17.

Live cold-adapted influenza A vaccine produced in Vero cell line.

Romanova J, Katinger D, Ferko B, Vcelar B, Sereinig S, Kuznetsov O, Stukova M, Erofeeva M, Kiselev O, Katinger H, Egorov A.

Virus Res. 2004 Jul;103(1-2):187-93.

PMID:
15163508
18.

Evaluation of live avian-human reassortant influenza A H3N2 and H1N1 virus vaccines in seronegative adult volunteers.

Snyder MH, Clements ML, Betts RF, Dolin R, Buckler-White AJ, Tierney EL, Murphy BR.

J Clin Microbiol. 1986 May;23(5):852-7.

19.

PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus.

Kiseleva IV, Voeten JT, Teley LC, Larionova NV, Drieszen-van der Cruijsen SK, Basten SM, Heldens JG, van den Bosch H, Rudenko LG.

J Gen Virol. 2010 Apr;91(Pt 4):931-7. doi: 10.1099/vir.0.017996-0. Epub 2009 Dec 9.

PMID:
20007357
20.

Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.

Treanor JJ, Roth FK, Betts RF.

J Clin Microbiol. 1990 Mar;28(3):596-9. Erratum in: J Clin Microbiol 1990 Jun;28(6):1491.

Supplemental Content

Support Center